A detailed history of Ancora Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 588 shares of CORT stock, worth $32,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
588
Previous 588 -0.0%
Holding current value
$32,216
Previous $19,000 42.11%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $306,498 - $475,823
-13,800 Reduced 95.91%
588 $19,000
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $303,586 - $395,094
14,388 New
14,388 $362,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.87B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.